Sodium danshensu attenuates cerebral ischemia–reperfusion injury by targeting AKT1
The beneficial properties of Sodium Danshensu (SDSS) for controlling cerebral ischemia and reperfusion injury (CIRI) are elucidated here both in vivo and in vitro. SDSS administration significantly improved the viability of P12 cells, reduced lactate dehydrogenase (LDH) leakage, and decreased the ap...
Main Authors: | Qing Gao, Hao Deng, Zhengfei Yang, Qiuyue Yang, Yilin Zhang, Xiaopeng Yuan, Miao Zeng, Maojuan Guo, Wenyun Zeng, Xijuan Jiang, Bin Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.946668/full |
Similar Items
-
Sodium Danshensu stabilizes atherosclerotic vulnerable plaques by targeting IKKβ mediated inflammation in macrophages
by: Miao Zeng, et al.
Published: (2023-09-01) -
Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool
by: Xiao-yi Bao, et al.
Published: (2018-12-01) -
Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo
by: Tian Wang, et al.
Published: (2020-01-01) -
Sodium Danshensu mediates human T lymphocyte activation via NF‐κB and MAPK pathway regulation
by: Yanan Chen, et al.
Published: (2022-09-01) -
Danshensu Attenuated Epithelial-Mesenchymal Transformation and Chemoresistance of Colon Cancer Cells Induced by Platelets
by: Yuzhu Cao, et al.
Published: (2022-05-01)